DNA and the classical way: Identification of medically important molds in the 21st century
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The advent of the 21st century has seen significant advances in the methods and practices used for identification of medically important molds in the clinical microbiology laboratory. Historically, molds have been identified by using observations of colonial and microscopic morphology, along with tables, keys and textbook descriptions. This approach still has value for the identification of many fungal organisms, but requires expertise and can be problematic in determining a species identification that is timely and useful in the management of high-risk patients. For the increasing number of isolates that are uncommon, atypical, or unusual, DNA-based identification methods are being increasingly employed in many clinical laboratories. These methods include the commercially available GenProbe assay, methods based on the polymerase chain reaction such as single-step PCR, RAPD-PCR, rep-PCR, nested PCR, PCR-RFLP, PCR-EIA, and more recent microarray-based, Luminex technology-based, and real-time PCR-based methods. Great variation in assay complexity, targets, and detection methods can be found, and many of these methods have not been widely used or rigorously validated. The increasing availability of DNA sequencing chemistry has made comparative DNA sequence analysis an attractive alternative tool for fungal identification. DNA sequencing methodology can be purchased commercially or developed in-house; such methods display varying degrees of usefulness depending on the breadth and reliability of the databases used for comparison. The future success of sequencing-based approaches will depend on the choice of DNA target, the reliability of the result, and the availability of a validated sequence database for query and comparison. Future studies will be required to determine sequence homology breakpoints and to assess the accuracy of molecular-based species identification in various groups of medically important filamentous fungi. At this time, a polyphasic approach to identification that combines morphologic and molecular methods will ensure the greatest success in the management of patients with fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular systematics and phylogeography of the Gibberella fujikuroi species complex
O'Donnell, K., Cigelnik, E., & Nirenberg, H. I. (1998) · Mycologia · doi:10.1080/00275514.1998.12026933 · Cited by 963
Molecular Systematics and Phylogeography of the Gibberella fujikuroi Species Complex
O'Donnell, K., Cigelnik, E., & Nirenberg, H. I. (1998) · Mycologia · doi:10.2307/3761407 · Cited by 486
The Impact of Culture Isolation of Aspergillus Species: A Hospital‐Based Survey of Aspergillosis
Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., de Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W., Stevens, D. A., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/323900 · Cited by 458 · cited 1×
“On the other hand, it is also important to recognize that many fungal isolates recovered from clinical samples do not represent significant disease [1, 2 ], and that it can be inappropriate to devote resources to species identification without a clear understanding of the clinical relevance of that isolate.”
BackgroundRees, J. R., Pinner, R. W., Hajjeh, R. A., Brandt, M. E., & Reingold, A. L. (1998) · Clinical Infectious Diseases · doi:10.1093/clinids/27.5.1138 · Cited by 397
Self-citationApfalter, P., Reischl, U., & Hammerschlag, M. R. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5835-5841.2005 · Cited by 104
Cited by
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
Park, B. J., Pappas, P. G., Wannemuehler, K. A., Alexander, B. D., Anaissie, E. J., Andes, D. R., Baddley, J. W., Brown, J. M., Brumble, L. M., Freifeld, A. G., et al. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110087 · Cited by 321
Cassagne, C., Ranque, S., Normand, A.-C., Fourquet, P., Thiebault, S., Planard, C., Hendrickx, M., & Piarroux, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028425 · Cited by 257
Next-Generation Sequencing for Infectious Disease Diagnosis and Management
Lefterova, M. I., Suarez, C. J., Banaei, N., & Pinsky, B. A. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.07.004 · Cited by 207
Çakır, N., & Koc, A. N. (2021) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20210475 · Cited by 21
Metadata
- Authors
- Arunmozhi Balajee, S., Sigler, L., & Brandt, M. E.
- Venue
- Medical Mycology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01
- Volume
- 45
- Issue
- 6
- Pages
- 475-490
- ISSN
- 0268-1218 (ISSN-L)
- 1369-3786
- 1460-2709
- OpenAlex
- W1990365009
- Cited by
- 139
- References
- 5
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DNA and the classical way: Identification of medically important molds in the 21st century. https://app.cochat.ai/papers/10.1080/13693780701449425
- The paper
- Arunmozhi Balajee, S., Sigler, L., & Brandt, M. E. (2007). DNA and the classical way: Identification of medically important molds in the 21st century. Medical Mycology. https://doi.org/10.1080/13693780701449425
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.